Shiro Kubonishi Selected Research

Shiro Kubonishi Research Topics

2	Multiple Myeloma 02/2024 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 11/2009 - 05/2009
1	Mucormycosis 01/2022
1	Febrile Neutropenia 01/2022
1	Malignant Pleural Effusion 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Leukemia 01/2021
1	Neoplasms (Cancer) 08/2020
1	Mycoses (Diseases, Fungus) 08/2020
1	Breakthrough Infections 08/2020
1	Fever (Fevers) 08/2020
1	Osteomyelitis 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Lymphoma (Lymphomas) 01/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2014
1	Lymphadenopathy 01/2014
1	Acute Promyelocytic Leukemia 05/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2006

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
2	liposomal amphotericin B FDA Link 01/2022 - 08/2020
1	carfilzomibIBA 02/2024
1	posaconazole FDA Link 01/2022
1	Antifungal AgentsIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2021
1	blinatumomabIBA 01/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 08/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2017
1	Azacitidine (5 Azacytidine)FDA Link 01/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017
1	Rituximab (Mabthera)FDA Link 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	fludarabineIBA 01/2014
1	Cyclin D1IBA 01/2014
1	Bendamustine Hydrochloride FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 05/2006
1	Gefitinib (Iressa)FDA Link 05/2006
1	ErbB Receptors (EGF Receptor)IBA 05/2006

5	Therapeutics 01/2021 - 11/2009
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2017
2	Transplantation 11/2009 - 05/2009
1	Remission Induction 01/2017
1	Induction Chemotherapy 01/2017
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Homologous Transplantation 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2014